In Brief This Week: Thermo Fisher Scientific, Enzo Biochem, Codex DNA, More
News items for the week of Oct. 10, 2022.
Bluestar Genomics Gets CLIA Certification
The company said that the certification will enable it to perform its epigenomic pancreatic cancer test within its own laboratory.
Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership
The complaint focuses on a recent patent filed by Chunxiao Song, the consultant, alleging that it falls within the terms of his contract with Bluestar.
Bluestar Genomics Raises $70M in Series C Funding Round
The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board.
Bluestar hopes to launch a pan-cancer, DNA methylation-based liquid biopsy assay as a laboratory-developed test out of an envisioned CLIA-certified lab in San Diego.